| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
16,341 |
15,032 |
$1.72M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,501 |
6,625 |
$1.21M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,781 |
2,470 |
$250K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,589 |
3,388 |
$212K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,025 |
864 |
$166K |
| J3490 |
Unclassified drugs |
19,042 |
11,129 |
$140K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
805 |
760 |
$119K |
| 71046 |
Radiologic examination, chest; 2 views |
1,427 |
1,346 |
$100K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,261 |
971 |
$97K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,042 |
1,895 |
$90K |
| 80053 |
Comprehensive metabolic panel |
9,230 |
8,357 |
$88K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,430 |
8,544 |
$75K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
849 |
761 |
$62K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
44 |
39 |
$58K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,136 |
996 |
$57K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,125 |
1,001 |
$26K |
| 81001 |
|
5,623 |
5,160 |
$20K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
310 |
303 |
$17K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
472 |
434 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
712 |
690 |
$11K |
| 81025 |
|
1,257 |
1,165 |
$11K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
420 |
368 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
3,447 |
3,064 |
$10K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,015 |
954 |
$9K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
12 |
12 |
$9K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,339 |
1,231 |
$9K |
| 84484 |
|
1,078 |
905 |
$9K |
| 70450 |
Computed tomography, head or brain; without contrast material |
18 |
15 |
$8K |
| 83690 |
|
1,026 |
938 |
$8K |
| 87631 |
|
79 |
77 |
$7K |
| 71045 |
Radiologic examination, chest; single view |
118 |
106 |
$7K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
120 |
112 |
$6K |
| 87081 |
|
764 |
739 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
131 |
111 |
$6K |
| 36592 |
|
399 |
371 |
$5K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
59 |
52 |
$5K |
| 85027 |
|
511 |
461 |
$4K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
55 |
52 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
87 |
85 |
$4K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
20 |
19 |
$4K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
155 |
134 |
$4K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
35 |
32 |
$3K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
97 |
81 |
$2K |
| 80061 |
Lipid panel |
122 |
116 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
90 |
83 |
$2K |
| A9270 |
Non-covered item or service |
1,784 |
924 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
255 |
232 |
$1K |
| 84439 |
|
88 |
81 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
89 |
85 |
$1K |
| 87186 |
|
77 |
69 |
$902.08 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
72 |
69 |
$777.94 |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
126 |
110 |
$718.04 |
| 85379 |
|
58 |
52 |
$692.85 |
| 85610 |
|
187 |
173 |
$646.11 |
| 87077 |
|
61 |
53 |
$627.97 |
| 80076 |
|
41 |
38 |
$414.63 |
| 83525 |
|
24 |
24 |
$359.04 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
18 |
15 |
$325.00 |
| 83605 |
|
14 |
13 |
$171.86 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
13 |
13 |
$158.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
12 |
12 |
$65.79 |
| 85730 |
|
12 |
12 |
$59.84 |
| 82962 |
|
14 |
12 |
$43.89 |